Cancer 
        Digest        

Alyssa Tapley was the first patient to undergo a new gene therapy called BE-CAR7 for her T-cell acute lymphoblastic leukemia, a previously untreatable form of cancer. She has been cancer-free for more than three years. (Image credit – University College of London) CANCER DIGEST – Dec. 27, 2025 – Using a more precise genetic editing technique researchers at the University College of Lindon, in the United Kingdom have developed an advanced form of CAR-T cell therapy that has el

A clinical study has shown that a new protocol for stem cell or bone marrow transplantation with unmatched donors achieves outcomes comparable to patients with fully matched donors. 

Diagram shows signs and symptoms of Multiple Myeloma – Image credit Multiple Myeloma Foundation CANCER DIGEST – June 8, 2025 – The...

Eight of 11 patients (72.7%) treated in a early stage international clinical trial of a new drug for a rare form of blood cancer achieved complete remission, meaning there were no signs of cancer after treatment, a new study shows.

Sequence of treatment matters in second-line and third-line therapy for a certain type of blood cancer

CANCER DIGEST – March 8, 2025 – When most people get a tattoo, their health concerns center almost entirely on cleanliness and risk of...

A new drug is showing promise of significantly reducing one of the most serious complications of stem cell transplants in results of an earl

In a first test of more typical patients with multiple myeloma, a newly FDA-approved drug proved nearly as effective as in clinical trial

CANCER DIGEST – July 28, 2024 – A new analysis shows that women 18-35 who have been treated for cancer or other diseases with allogeneic...

In a small study, half of the patients whose lymphoma failed to respond to all previous treatments including CAR T-cell therapy, responded